Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

J Infect Dis. 1987 May;155(5):1043-7. doi: 10.1093/infdis/155.5.1043.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Viral / biosynthesis
  • Humans
  • Immunoglobulin A, Secretory / biosynthesis
  • Immunoglobulin E / biosynthesis*
  • Infant
  • Nasopharynx / metabolism
  • Respiratory Syncytial Viruses / immunology*
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / immunology*
  • Respirovirus Infections / drug therapy
  • Respirovirus Infections / immunology*
  • Ribavirin / therapeutic use*
  • Ribonucleosides / therapeutic use*

Substances

  • Antibodies, Viral
  • Immunoglobulin A, Secretory
  • Ribonucleosides
  • Immunoglobulin E
  • Ribavirin